TLMdX from AASLD 2020
November 13—16, 2020
While we are gathering our agenda, we invite you to subscribe to be notified when this event page is available
TLMdX DAY 2
TLMdX DAY 3
TLMdX DAY 4
TLMdX Wrap Up
TLMdX DAY 2
Saturday, Nov 14, 2020
Our Surfers Discussed The Following Papers and Sessions on Day 2
Today’s Episode Is Sponsored By
Sonic Incytes is on a mission to reduce chronic liver disease by enabling routine assessment and management of liver health. Its breakthrough, point of care ultrasound solution, Velacur™, assesses and manages chronic liver disease with diagnostic accuracy that is comparable to MRI. Learn more: www.sonicincytes.com
Surfing The NASH Tsunami Podcast Day 2
TLMdX DAY 3
Sunday, Nov 15, 2020
Our Surfers Discussed The Following Papers and Sessions on Day 3
Surfing The NASH Tsunami Podcast Day 3
TLMdX DAY 4
Monday, Nov 16, 2020
Our Surfers Discussed The Following Papers and Sessions on Day 4
Roger Green —
L03 – ALDAFERMIN (NGM282) PRODUCES GREATER ANTI-FIBROTIC RESPONSE IN PATIENTS WITH NONALCOHOLIC STREATOHEPATITIS AND ADVANCED FIBROSIS
&
0143
ONSET OF OBESITY-RELATED PEDIATRIC NONALCOHOLIC FATTY LIVER DISEASE (PNAFLD) DURING PREPUBERTAL GROWTH EXACERBATES HEPATIC INFLAMMATION AND MITOCHONDRIAL DNA DEPLETION TO ACCELERATE LIVER INJURY
Surfing The NASH Tsunami Podcast Day 4
TLMdX Wrap Up